StockData
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc. (BIO) stock

BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3069% below fair value
$366.36−4.12 (-1.11%)

Close on Nov 13, 2026Market cap $9.92BP/E 9.8Yield –

Bio-Rad Laboratories price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Bio-Rad Laboratories's price to sales ratio was 4.0× on Nov 11, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 2.5× to 7.7×, with a median of 3.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.0×+0.8
2025Dec 31, 20253.3×−0.4
2024Dec 31, 20243.6×+0.1
2023Dec 29, 20233.5×−1.0
2022Dec 30, 20224.5×−3.2
2021Dec 31, 20217.7×+0.3
2020Dec 31, 20207.4×+2.6
2019Dec 31, 20194.8×+1.8
2018Dec 31, 20183.1×−0.3
2017Dec 29, 20173.4×+0.8
2016Dec 30, 20162.6×+0.6
2015Dec 31, 20152.0×+0.4
2014Dec 31, 20141.6×−0.1
2013Dec 31, 20131.7×+0.2
2012Dec 31, 20121.5×+0.1
2011Dec 30, 20111.3×−0.2
2010Dec 31, 20101.5×+0.0
2009Dec 31, 20091.5×–

More Bio-Rad Laboratories figures

See a number that looks wrong?